title: Examining risperidone use in those diagnosed with autism 1 year after FDA approval.
authors.forename: Maria G
authors.initials: MG
authors.lastname: Valdovinos
authors.forename: Linda
authors.initials: L
authors.lastname: Bailey
authors.forename: Steve L
authors.initials: SL
authors.lastname: Taylor
mesh_terms: D000293:Adolescent; D000328:Adult; D017668:Age of Onset; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D001321:Autistic Disorder / Q000150:complications / Q000188:drug therapy*; D002648:Child; D006801:Humans; D008607:Intellectual Disability / Q000150:complications; D008875:Middle Aged; D018967:Risperidone / Q000627:therapeutic use*; D055815:Young Adult
chemical_list: D014150:Antipsychotic Agents; D018967:Risperidone